| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $73.3M | +12.4% |
| SG&A Expense | $22.8M | +15.5% |
| Operating Income | -$96.1M | -13.1% |
| Pre-tax Income | -$86.8M | -13.8% |
| Income Tax | $112K | -18.2% |
| Net Income | -$86.9M | -13.8% |
| EPS (Basic) | -$1.75 | +9.3% |
| EPS (Diluted) | -$1.75 | +9.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $31.7M | -22.8% |
| Current Assets | $160.6M | -30.7% |
| Total Assets | $182.5M | -28.5% |
| Current Liabilities | $14.9M | +20.7% |
| Total Liabilities | $30.5M | +4.5% |
| Stockholders' Equity | $152.0M | -32.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$79.8M | -25.0% |
| Capital Expenditures | $1.3M | +76.7% |
| Investing Cash Flow | $68.8M | +160.4% |
| Financing Cash Flow | $1.6M | -98.4% |
| Free Cash Flow | -$81.1M | -25.6% |